Total Funding
46
42
Total FundingSeries B raised
Growth Score
-10 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
23238
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Acquired by 
Sail Biomedicines
- Yann Echelard: Founding Team
- Tej Pavoor: Chief Operating Officer
About the Company
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery.
Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly
scaling to support the parallel development of multiple programs across many disease areas.
Women Founded
